论文部分内容阅读
目的:研究抗病毒胶囊联合利巴韦林注射液治疗小儿流行性腮腺炎的临床效果。方法:选取2012年1月~2013年1月我院诊治的小儿流行性腮腺炎患者120例,随机分为实验组(60例)和对照组(60例),对照组单纯应用利巴韦林,实验组应用抗病毒胶囊联合利巴韦林注射液,观察2组患者疗效。结果:实验组治愈42例,好转14例,总有效93.33%;对照组治愈28例,好转17例,总有效率为75.00%,2组差异显著(P<0.05)。结论:抗病毒胶囊联合利巴韦林注射液治疗小儿流行性腮腺炎的治疗效果显著,为临床联合用药提供一定的参考。
Objective: To study the clinical effect of antivirus capsule combined with ribavirin injection in the treatment of mumps in children. Methods: A total of 120 children with mumps diagnosed and treated in our hospital from January 2012 to January 2013 were randomly divided into experimental group (60 cases) and control group (60 cases). The control group was treated with ribavirin In the experimental group, anti-virus capsule and ribavirin injection were used to observe the curative effect of the two groups. Results: In the experimental group, 42 cases were cured, 14 cases improved, the total effective rate was 93.33%. In the control group, 28 cases were cured and 17 cases improved. The total effective rate was 75.00%. There was significant difference between the two groups (P <0.05). Conclusion: Antiviral capsule combined with ribavirin injection in the treatment of children with mumps significant therapeutic effect, provide a reference for the clinical combination therapy.